This classical understanding of the RAS has underpinned decades of therapeutic strategies targeting hypertension and cardiovascular disease, primarily through the use of angiotensin converting enzyme inhibitors (ACE-i), angiotensin receptor blockers (ARBs), and direct renin inhibitors [151]. The gene discussed is ACE; the disease is cardiovascular disorder.